Ginsenoside Rg3

CAS : 14197-60-5

Ref. TR-G387590

Informations sur le produit

• Nom: Ginsenoside Rg3
• Synonymes: β-D-Glucopyranoside, (3β,12β)-12,20-dihydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-, Dammar-24-ene-12β,20-diol, 3β-[(2-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]- (8CI), Dammarane, β-D-glucopyranoside deriv., (20S)-Propanaxadiol, (3β,12β)-12,20-Dihydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside, (3β,12β)-12,20-Dihydroxydammar-24-en-3-yl O-β-D-glucopyranosyl-(1→2)-β-D-glucopyranoside, 20(S)-Ginsenoside-Rg3, 20(S)-Rg3, 20S-Ginsenoside Rg3, 3-O-β-D-Glucopyranosyl-(1→2)-β-D-glucopyranosyldammar-24-ene-3β,12β,20S-triol, Ginsenoside 20-Rg3
• Marque: TRC
• Description: Applications Ginsenoside Rg3 shows a synergistic antitumor effect with cisplatin in cisplatin-resistant bladder tumor cell lines and is considered to be an anti-tumor agent.References Lee, Y; et al.: Onc. Rep., 32, 1803 (2014); Ge, X. et al.: J. Int. Med. Res., 42, 628 (2014)

Propriétés chimiques

• Masse moléculaire: 785.01
• Formule: C₄₂H₇₂O₁₃
• Couleur/Forme: Neat
• InChI: InChI=1S/C42H72O13/c1-21(2)10-9-14-42(8,51)22-11-16-41(7)29(22)23(45)18-27-39(5)15-13-28(38(3,4)26(39)12-17-40(27,41)6)54-37-35(33(49)31(47)25(20-44)53-37)55-36-34(50)32(48)30(46)24(19-43)52-36/h10,22-37,43-51H,9,11-20H2,1-8H3/t22-,23+,24+,25+,26-,27+,28-,29-,30+,31+,32-,33-,34+,35+,36-,37-,39-,40+,41+,42-/m0/s1
• Code InChI: InChIKey=RWXIFXNRCLMQCD-QOTMNCTRSA-N
• SMILES: CC(C)=CCCC(C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4OC(CO)[C@@H](O)C(O)C4O[C@@H]4OC(CO)[C@@H](O)C(O)C4O)C(C)(C)[C@@H]3CC[C@]12C